FLETCHER MUNKSGARD: Open Payments
NPI 1992243331 · CUPERTINO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,298 in 70 payments from 15 companies in 2025. Trend: 2023 $90 · 2024 $775 · 2025 $2,298
Food & beverage: $2,298
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $486 |
| Vanda Pharmaceuticals Inc. | 12 | $401 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $342 |
| Axsome Therapeutics, Inc. | 8 | $193 |
| Lilly USA, LLC | 6 | $133 |
| PFIZER INC. | 2 | $125 |
| Lundbeck LLC | 4 | $124 |
| Corcept Therapeutics | 1 | $116 |
| UCB, Inc. | 3 | $108 |
| Amneal Pharmaceuticals LLC | 3 | $73 |
Products named: CAPLYTA, FANAPT, QULIPTA, VRAYLAR, Auvelity, NURTEC ODT, REXULTI, Korlym.
Industry payments across CA — which companies pay providers there.
